MultipleMS has 22 partners originating from 15 countries, with the main hub at the Karolinska Institutet, Stockholm, Sweden. The consortium will grow by addition of new centres of excellence during the project phase.
- Department of Clinical Neuroscience, Centre for Molecular Medicine, Karolinska Institutet, Stockholm SE
- Mabtech AB (Swedish biotech company), Stockholm SE
- YouHealth AB (Swedish bioinformatics company), Stockholm SE
- Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki FI
- Biocomputing Platforms Oy, (Finnish bioinformatics company), Espoo FI
- Department of Neurology, University of Oslo, Oslo NO
- Department of Neurology, Danish Multiple Sclerosis Center, Rigshospitalet, Copenhagen DK
- TUM School of Medicine, Technical University of Munich, Munich DE
- Department of Neurosciences, KU Leuven, Leuven BE
- Department of Cancer Biology, University College London, London UK
- MedImmune (AstraZeneca), Cambridge UK
- Department of Clinical Neurosciences, University of Cambridge, Cambridge UK
- European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton UK
- NEURIX (Swiss biotech company), Geneva CH
- Institut d’Investigacions Biomediques August Pi Sunye (IDIBAPS), Barcelona ES
- Laboratory of Human Genetics of Neurological Disoders and Department of Neurology, Institute of Experimental Neurology, Division of Neuroscience, Scientific Institute San Raffaele, Milan IT
- Department of Health Sciences, Università del Piemonte Orientale, Novara IT
- Department of Neurology, University of California and San Francisco, San Francisco USA
- ALTIUS Institute for Biomedical Sciences, Seattle USA
- Department of Mathematics, KTH Royal Institute of Technology, Stockholm SE
- Sanofi-Aventis Research and Development, Chilly-Mazarin FR
- IRCCS Policlinico San Donato, IT
Consulting through: - PricewaterhouseCoopers, Amsterdam, Netherlands
